← Back to headlines
Summit Therapeutics Warns of Potential Business Impact Due to Cash Crunch
Summit Therapeutics has stated that a significant cash crunch could jeopardize its ability to continue operations, raising concerns about the company's future.
23 Jul, 21:34 — 23 Jul, 21:34
Sources
Showing 1 of 1 sources
